MedTrace Logo

High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity

NCT04500392 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2024-01-11

No results posted yet for this study

Summary

Hypoxia is the most common adverse event during gastrointestinal endoscopes sedated with propofol and sufentanil, especially in obese people. In the present study, high-flow nasal cannula oxygenation will be utilized in order to reduce the incidence of hypoxia among obesity.

Conditions

Interventions

DEVICE

High-flow nasal cannula oxygenation

Oxygen is supplied with a high-flow nasal cannula oxygenation device#the flow is up to 60L/min

DEVICE

Regular nasal cannula

Oxygen is supplied with a regular nasal cannula #the flow is up to 6L/min

Sponsors & Collaborators

  • Shanghai Tongji Hospital, Tongji University School of Medicine

    collaborator OTHER

  • Shanghai Oriental Hospital, Tongji University School of Medicine

    collaborator UNKNOWN

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Diansan Su, Dr. · Renji Hospital, Shanghai Jiaotong University, Shanghai, China

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04500392 on ClinicalTrials.gov